Literature DB >> 19369513

Commensal bacteria can enter colonic epithelial cells and induce proinflammatory cytokine secretion: a possible pathogenic mechanism of ulcerative colitis.

Toshifumi Ohkusa1, Tsutomu Yoshida2, Nobuhiro Sato3, Sumio Watanabe3, Hisao Tajiri1, Isao Okayasu2.   

Abstract

Interleukin 2 (IL-2)- and IL-10-knockout mice develop spontaneous colitis under conventional but not germ-free conditions, suggesting that commensal bacteria play an important role in the pathogenesis of colitis. However, interactions between commensal bacteria and colonic epithelial cells have not been fully investigated. We therefore assessed the ability of various commensal bacteria and probiotics to adhere to and invade colonic epithelial cells. Effects of the bacteria on production of proinflammatory cytokines were also measured. Commensal bacteria, including mucosal organisms isolated from ulcerative colitis (UC) patients, such as Fusobacterium varium, reported as a possible pathogen in UC, Bacteroides vulgatus, Escherichia coli and Clostridium clostridioforme, as well as their type strains and probiotics, were assessed for their ability to adhere to and invade colonic epithelial cells using two cell lines, SW-480 and HT-29. Our experiments employed co-incubation, a combination of scanning and transmission electron microscopy and recovery of bacteria from infected-cell lysates. F. varium and several other commensal bacteria, but not probiotics, adhered to colonic epithelial cells and invaded their cytoplasm. ELISA and real-time PCR revealed that the host cells, particularly those invaded by F. varium, showed significant increases in IL-8 and TNF-alpha concentrations in supernatants, with elevation of IL-8, TNF-alpha, MCP-1 and IL-6 mRNAs. Furthermore, IL-8 and TNF-alpha expression and nuclear phosphorylated NF-kappaB p65 expression could be immunohistochemically confirmed in inflamed epithelium with cryptitis or crypt abscess in UC patients. Certain commensal bacteria can invade colonic epithelial cells, activating early intracellular signalling systems to trigger host inflammatory reactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369513      PMCID: PMC2887547          DOI: 10.1099/jmm.0.005801-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  32 in total

1.  An index of disease activity in patients with ulcerative colitis.

Authors:  M Seo; M Okada; T Yao; M Ueki; S Arima; M Okumura
Journal:  Am J Gastroenterol       Date:  1992-08       Impact factor: 10.864

2.  Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45.

Authors:  M Aihara; D Tsuchimoto; H Takizawa; A Azuma; H Wakebe; Y Ohmoto; K Imagawa; M Kikuchi; N Mukaida; K Matsushima
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

3.  Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium.

Authors:  T Kuhara; M Iigo; T Itoh; Y Ushida; K Sekine; N Terada; H Okamura; H Tsuda
Journal:  Nutr Cancer       Date:  2000       Impact factor: 2.900

4.  Salmonella typhi stimulation of human intestinal epithelial cells induces secretion of epithelial cell-derived interleukin-6.

Authors:  D L Weinstein; B L O'Neill; E S Metcalf
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

5.  Fusobacterium varium localized in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody.

Authors:  Toshifumi Ohkusa; Nobuhiro Sato; Tatuo Ogihara; Koji Morita; Masayuki Ogawa; Isao Okayasu
Journal:  J Gastroenterol Hepatol       Date:  2002-08       Impact factor: 4.029

6.  IL-8 is a key chemokine regulating neutrophil recruitment in a new mouse model of Shigella-induced colitis.

Authors:  Monique Singer; Philippe J Sansonetti
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

7.  Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin 8.

Authors:  L Eckmann; H C Jung; C Schürer-Maly; A Panja; E Morzycka-Wroblewska; M F Kagnoff
Journal:  Gastroenterology       Date:  1993-12       Impact factor: 22.682

8.  Apoptosis regulation differs between ulcerative colitis-associated and sporadic colonic tumors. Association with survivin and bcl-2.

Authors:  Tetuo Mikami; Tsutomu Yoshida; Fumiyuki Akino; Tadashi Motoori; Mioko Yajima; Isao Okayasu
Journal:  Am J Clin Pathol       Date:  2003-05       Impact factor: 2.493

9.  Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex.

Authors:  Manabu Suzuki; Tadakazu Hisamatsu; Daniel K Podolsky
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Dysregulated expression of COOH-terminally truncated Stat5 and loss of IL2-inducible Stat5-dependent gene expression in Sezary Syndrome.

Authors:  Tracey J Mitchell; Sean J Whittaker; Susan John
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

View more
  62 in total

1.  Role of gut microbiota in a zebrafish model with chemically induced enterocolitis involving toll-like receptor signaling pathways.

Authors:  Qi He; Lin Wang; Fan Wang; Qiurong Li
Journal:  Zebrafish       Date:  2014-04-23       Impact factor: 1.985

2.  Fusobacterium varium in ulcerative colitis: is it population-based?

Authors:  Emma Allen-Vercoe
Journal:  Dig Dis Sci       Date:  2014-10-14       Impact factor: 3.199

Review 3.  Immune reaction and colorectal cancer: friends or foes?

Authors:  Vincenzo Formica; Vittore Cereda; Antonella Nardecchia; Manfredi Tesauro; Mario Roselli
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

Review 4.  The microbiome in inflammatory bowel disease: current status and the future ahead.

Authors:  Aleksandar D Kostic; Ramnik J Xavier; Dirk Gevers
Journal:  Gastroenterology       Date:  2014-02-19       Impact factor: 22.682

5.  Production of corticotropin-releasing factor and urocortin from human monocyte-derived dendritic cells is stimulated by commensal bacteria in intestine.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Shin Kan; Kazuki Takakura; Keisuke Saito; Hideo Komita; Zensho Ito; Hiroko Kobayashi; Shinichiro Takami; Kan Uchiyama; Hiroshi Arakawa; Masaki Ito; Masato Okamoto; Mikio Kajihara; Sadamu Homma; Hisao Tajiri
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

6.  Draft genome sequence of Bacteroides vulgatus PC510, a strain isolated from human feces.

Authors:  Páraic Ó Cuív; Eline S Klaassens; A Scott Durkin; Derek M Harkins; Les Foster; Jamison McCorrison; Manolito Torralba; Karen E Nelson; Mark Morrison
Journal:  J Bacteriol       Date:  2011-05-27       Impact factor: 3.490

7.  CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid.

Authors:  Tsutomu Yoshida; Tsukasa Sekine; Ken-ichi Aisaki; Tetuo Mikami; Jun Kanno; Isao Okayasu
Journal:  J Gastroenterol       Date:  2010-12-17       Impact factor: 7.527

Review 8.  How the evolving epidemics of opioid misuse and HIV infection may be changing the risk of oral sexually transmitted infection risk through microbiome modulation.

Authors:  Wiley D Jenkins; Lauren B Beach; Christofer Rodriguez; Lesli Choat
Journal:  Crit Rev Microbiol       Date:  2020-01-30       Impact factor: 7.624

9.  Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha.

Authors:  Poonam Dharmani; Jaclyn Strauss; Christian Ambrose; Emma Allen-Vercoe; Kris Chadee
Journal:  Infect Immun       Date:  2011-05-02       Impact factor: 3.441

10.  Reduced intestinal epithelial mitochondrial function enhances in vitro interleukin-8 production in response to commensal Escherichia coli.

Authors:  Alpana Saxena; Fernando Lopes; Derek M McKay
Journal:  Inflamm Res       Date:  2018-07-20       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.